Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial (Q37275571)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 July 2013
edit
Language Label Description Also known as
English
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
scientific article published on 15 July 2013

    Statements

    Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial (English)
    0 references
    0 references
    Richard G Bach
    Manuel Lombardero
    Saul Genuth
    Thomas W Donner
    Alan Garber
    Laurence Kennedy
    E Scott Monrad
    Sheryl F Kelsey
    Robert L Frye
    BARI 2D Investigators
    15 July 2013
    128
    785-794

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit